Quality Assurance (QA)

Avoid FDA 483 in 2026: Common Pharmaceutical Compliance Mistakes & Expert Solutions

In 2026, pharmaceutical compliance is no longer limited to traditional GMP documentation. Regulators globally are focusing on data integrity, AI governance, digital quality systems, contamination control, laboratory reliability, batch release justification, and supply-chain oversight. The core message is clear: a Read More …

Avoid CAPA Failure: Critical Writing Considerations in Pharmaceutical Industry

CAPA (Corrective and Preventive Action) is not just a documentation exercise—it is a regulatory expectation under Pharmaceutical Quality System (PQS) as per World Health Organization, US Food and Drug Administration, and International Council for Harmonisation. 🧩 1. Define the Problem Read More …

Technology Transfer in Pharmaceutical R&D (SEO-Optimized Detailed Guide)

Introduction to Technology Transfer in Pharma R&D Technology Transfer (TT) in pharmaceutical research and development is a highly structured, science-driven, and GMP-regulated process that ensures seamless movement of a drug product from development to commercial manufacturing. In modern pharmaceutical industries—especially Read More …